Correction to: Surgical Management and Considerations for Patients with Localized High-Risk Prostate Cancer

Affiliations

• ¹ Department of Urology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1373, Houston, TX, 77030, USA.
• ² Department of Genitourinary Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• ³ Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• ⁴ Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• ⁵ Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• ⁶ Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• ⁷ Department of Urology, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, USA.
• ⁸ Department of Radiology, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, USA.
• ⁹ Neal Comprehensive Cancer Center, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, USA.
• ¹⁰ Department of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• ¹¹ Department of Urology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1373, Houston, TX, 77030, USA. bfchapin@mdanderson.org.